Herbalife Nutrition Ltd vs Raytheon Technologies Corp — how do they compare? Herbalife Nutrition Ltd trades at $11.75 (market cap $1.23B), while Raytheon Technologies Corp trades at $222.97 (market cap $301.71B). The key difference: Raytheon Technologies Corp is far larger — about 245.3× Herbalife Nutrition Ltd's market cap, and Raytheon Technologies Corp pays a 1.3% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.
| HLF | RTX | |
|---|---|---|
Market Cap | $1.23B | $301.71B |
Sector | Consumer Staples | Industrials |
52-Week High | $19.96 | $224.12 |
52-Week Low | $7.75 | $151.75 |
Enterprise Value | $3.06B | $332.26B |
Dividend Yield | — | 1.3% |
Signals from Pluang's Aura AI — not financial advice
HLF trades at $11.71, up 1.65% on the day, with a bearish technical signal from moving averages. The company shows mixed earnings, missing Q2 2026 EPS estimates but achieving four consecutive quarters of sales growth. Valuation ratios appear attractive with a P/E of 7.53 and P/S of 0.24, though negative shareholder equity and high debt levels present financial risks. Recent news includes a planned CFO transition and inclusion in TIME's America's Best Companies 2026 list.
The outlook for HLF balances low valuation against operational and financial challenges. Investment opportunity lies in potential margin improvement and debt reduction, but risks include earnings volatility, high leverage, and competitive pressures in the nutrition space. Analyst sentiment is cautiously optimistic with a majority buy rating.
RTX trades at $224.12, up 0.49% today, near its 52-week high. The stock shows strong technical momentum with bullish moving averages and support at $223. Fundamentally, revenue grew to $88.6B in 2025 with net income of $6.73B, and recent contract wins like the $515M SPY-6 radar award bolster growth prospects. Earnings have consistently beaten estimates, with Q2 2026 EPS of $1.89 exceeding expectations.
The outlook is positive given robust defense spending and operational execution, but valuation multiples like a P/E of 39.41 pose risks if growth slows. Analyst consensus is bullish with a $233.14 price target, though overbought RSI levels suggest near-term consolidation may occur. Key risks include execution delays and macroeconomic pressures on defense budgets.
Trailing returns across standard periods
Latest headlines on both assets
Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →